Anika Therapeutics (ANIK) EBITDA Margin (2010 - 2026)
Anika Therapeutics' EBITDA Margin was 13.67% in Q2 2026, up 23.47 percentage points from -9.79% a year earlier and up 27.46 percentage points from the prior quarter.
Powered by 
Analysis
Anika Therapeutics (ANIK) EBITDA Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Anika Therapeutics' EBITDA Margin was 0.42% through Jun 30, 2026, up 2.38 percentage points year-over-year; for FY2025, it was -4.72%, down 7.24 percentage points from FY2024.
- EBITDA Margin has now declined for three consecutive years, though with a five-year change of +6.67 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 2.52% in FY2024 (-9.95 pp), 12.47% in FY2023 (-3.48 pp), 15.95% in FY2022 (+4.49 pp) and 11.46% in FY2021 (+22.85 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q2 2021.
- Compared with a year earlier, EBITDA Margin was higher in three of the last seven quarters, with an average year-over-year change of +0.97 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2021 (a gain of 43.38 percentage points); the worst was Q2 2022 (a drop of 32.42 percentage points).
- Per Business Quant data, ANIK's EBITDA Margin in the three quarters before Q2 2026 was -13.78% (Q1 2026), 6.42% (Q4 2025) and -6.58% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.62% |
| 10 | Anika Therapeutics | 266.86 Mn | 309,027.15 | 21.24 Mn | 13.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.67% |
| Mar 31, 2026 | -13.78% |
| Dec 31, 2025 | 6.42% |
| Sep 30, 2025 | -6.58% |
| Jun 30, 2025 | -9.79% |
| Mar 31, 2025 | -10.29% |
| Dec 31, 2024 | 3.62% |
| Sep 30, 2024 | 7.13% |
| Jun 30, 2024 | 0.81% |
| Mar 31, 2024 | -1.52% |
| Sep 30, 2023 | -9.97% |
| Jun 30, 2023 | -0.18% |
| Mar 31, 2023 | -23.74% |
| Sep 30, 2022 | -5.72% |
| Jun 30, 2022 | 0.83% |
| Mar 31, 2022 | 0.17% |
| Dec 31, 2021 | -15.06% |
| Sep 30, 2021 | 12.33% |
| Jun 30, 2021 | 33.25% |
| Mar 31, 2021 | 13.90% |
API Access
Anika Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ANIK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ANIK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ANIK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();